About Seawolf Therapeutics
Leadership Team
Elizabeth Alcamo, PhD
President & CEO
Rob Burke, PhD
Chief Scientific Officer
Ramon Diaz Trelles
Head of Payload Engineering
Melissa Gutierrez
Head of Facilities
Amit Sagi
Head of Delivery Technologies
Laura Smith
Head of Development Sciences
Board Members and Observers
Tom Woiwode, PhD (chair)
Managing Director, Versant Ventures
Elizabeth Alcamo, PhD
President & CEO,
Seawolf Therapeutics
Laura Brass, PhD, MBA
Managing Director,
Novartis Venture Fund
Adam Cotton, PhD, MBA (observer)
Associate, Novartis Venture Fund
Daniel Faga, MBA
President & CEO, Anaptys Bio
Todd Foley, MBA
Managing Director,
MPM BioImpact
Ritikesh Kumar, MBA (observer)
CRISPR Therapeutics
Ben Yaden, PhD (observer)
Eli Lilly Corporation
Investors
